BRIEF

on CureVac (NASDAQ:CVAC)

CureVac to Announce Q4 and Full-Year 2023 Results on April 24, 2024

CureVac N.V., a biopharmaceutical company specializing in mRNA-based therapies, is set to announce its fourth quarter and full-year 2023 financial results and business updates on April 24, 2024. The announcement will be accompanied by a conference call and webcast.

The event will occur at 3 p.m. CET, which translates to 9 a.m. EST, allowing global stakeholders to participate. Attendees can join the conference call using various dial-in numbers provided for U.S., international, and German participants. The webcast will be available on CureVac's website, with corresponding presentation slides to be uploaded shortly before the session begins. A replay of the webcast will also be provided on the website after the event concludes.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all CureVac news